IL117459A - Dna encoding human papillomavirus type 18 - Google Patents

Dna encoding human papillomavirus type 18

Info

Publication number
IL117459A
IL117459A IL11745996A IL11745996A IL117459A IL 117459 A IL117459 A IL 117459A IL 11745996 A IL11745996 A IL 11745996A IL 11745996 A IL11745996 A IL 11745996A IL 117459 A IL117459 A IL 117459A
Authority
IL
Israel
Prior art keywords
dna encoding
encoding human
human papillomavirus
papillomavirus type
type
Prior art date
Application number
IL11745996A
Other languages
English (en)
Other versions
IL117459A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117459(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/408,669 external-priority patent/US5840306A/en
Priority claimed from US08/409,122 external-priority patent/US5820870A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL117459A0 publication Critical patent/IL117459A0/xx
Publication of IL117459A publication Critical patent/IL117459A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11745996A 1995-03-22 1996-03-13 Dna encoding human papillomavirus type 18 IL117459A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/408,669 US5840306A (en) 1995-03-22 1995-03-22 DNA encoding human papillomavirus type 18
US08/409,122 US5820870A (en) 1995-03-22 1995-03-22 Recombinant human papillomavirus type 18 vaccine

Publications (2)

Publication Number Publication Date
IL117459A0 IL117459A0 (en) 1996-07-23
IL117459A true IL117459A (en) 2005-11-20

Family

ID=27020342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11745996A IL117459A (en) 1995-03-22 1996-03-13 Dna encoding human papillomavirus type 18

Country Status (22)

Country Link
EP (2) EP0817851B9 (pl)
JP (1) JPH11502704A (pl)
KR (1) KR100430698B1 (pl)
CN (1) CN1100876C (pl)
AT (1) ATE259879T1 (pl)
AU (1) AU714533B2 (pl)
CA (1) CA2215834C (pl)
CZ (1) CZ291242B6 (pl)
DE (4) DE122007000031I1 (pl)
DK (1) DK0817851T5 (pl)
EA (1) EA001092B1 (pl)
ES (1) ES2213772T3 (pl)
FR (1) FR07C0023I2 (pl)
HU (1) HU223761B1 (pl)
IL (1) IL117459A (pl)
NL (3) NL300272I1 (pl)
NO (1) NO322254B1 (pl)
NZ (1) NZ305188A (pl)
PL (1) PL184022B1 (pl)
PT (1) PT817851E (pl)
SK (1) SK284281B6 (pl)
WO (1) WO1996029413A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
WO1998044944A2 (en) * 1997-04-08 1998-10-15 Merck & Co., Inc. Stabilized human papillomavirus formulations
EP1105466B1 (en) * 1998-08-14 2006-04-26 Merck & Co., Inc. Process for purifying human papillomavirus virus-like particles
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
ATE413188T1 (de) 1999-02-05 2008-11-15 Merck & Co Inc Menschliche papillomavirus impfstoff- formulierungen
FR2795074A1 (fr) * 1999-05-21 2000-12-22 Inst Nat Sante Rech Med Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
RU2356943C2 (ru) * 2003-03-24 2009-05-27 Мерк Энд Ко., Инк. Молекула нуклеиновой кислоты, кодирующая hpv31 l1, экспрессирующий вектор, клетка-хозяин, вирусоподобная частица и способ ее получения, вакцина, фармацевтическая композиция и способы с их использованием
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
EP2154147B1 (en) 2007-04-29 2015-10-07 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. A truncated l1 protein of human papillomavirus 16
EP2147926B1 (en) * 2007-04-29 2016-08-24 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Truncated human papillomavirus type 18 l1 proteins
CN101440373B (zh) * 2007-11-23 2012-09-05 上海泽润生物科技有限公司 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
CA2768172A1 (en) * 2009-06-25 2010-12-29 Glaxosmithkline Biologicals S.A. Novel compositions
CN103717741B (zh) * 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
CN104203270A (zh) 2012-03-18 2014-12-10 葛兰素史密丝克莱恩生物有限公司 针对人乳头状瘤病毒的接种方法
CN108276491B (zh) * 2018-02-05 2021-01-12 南京薇熙生物医药科技有限公司 一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用
HUE073111T2 (hu) 2019-07-19 2026-01-28 Sinocelltech Ltd Kiméra papillomavírus L1 fehérje
ES3017868T3 (en) 2022-07-07 2025-05-13 Permobil Ab Powered midwheel drive wheelchair with standing capability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
EP1359156B1 (en) * 1991-07-19 2007-03-07 University of Queensland Vaccine against Human Papillomavirus (Type 18)
PT647140E (pt) * 1992-06-25 2007-12-27 Univ Georgetown Vacinas de papilomavírus
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE69434383T2 (de) * 1993-03-09 2005-11-24 The University Of Rochester Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen

Also Published As

Publication number Publication date
CN1100876C (zh) 2003-02-05
DE69631586D1 (de) 2004-03-25
JPH11502704A (ja) 1999-03-09
WO1996029413A2 (en) 1996-09-26
DE122007000031I1 (de) 2007-07-19
DE122007000030I1 (de) 2007-07-19
WO1996029413A3 (en) 1996-11-28
HUP9801334A3 (en) 1999-04-28
KR100430698B1 (ko) 2004-07-15
NO974322D0 (no) 1997-09-19
FR07C0023I2 (fr) 2012-08-03
NZ305188A (en) 1999-11-29
FR07C0023I1 (pl) 2007-04-27
HUP9801334A2 (hu) 1998-08-28
CA2215834C (en) 2007-06-12
EA199700256A1 (ru) 1999-06-24
HU223761B1 (hu) 2005-01-28
EP0817851B1 (en) 2004-02-18
CN1185176A (zh) 1998-06-17
DE69631586T9 (de) 2005-06-16
NL300271I1 (nl) 2007-05-01
NO322254B1 (no) 2006-09-04
AU714533B2 (en) 2000-01-06
CZ291242B6 (cs) 2003-01-15
SK127897A3 (en) 1998-07-08
NL300272I1 (nl) 2007-05-01
NL300273I1 (nl) 2007-05-01
NO974322L (no) 1997-11-24
PL184022B1 (pl) 2002-08-30
ATE259879T1 (de) 2004-03-15
EP0817851A2 (en) 1998-01-14
EP0817851B9 (en) 2004-08-18
DE69631586T2 (de) 2005-01-27
MX9707208A (es) 1997-11-29
ES2213772T3 (es) 2004-09-01
DK0817851T3 (da) 2004-08-16
PT817851E (pt) 2004-06-30
CZ293697A3 (cs) 1998-02-18
SK284281B6 (sk) 2004-12-01
DE122007000025I1 (de) 2007-07-12
IL117459A0 (en) 1996-07-23
CA2215834A1 (en) 1996-09-26
EA001092B1 (ru) 2000-10-30
EP1422294A1 (en) 2004-05-26
DK0817851T5 (da) 2004-10-25
AU5314196A (en) 1996-10-08
PL322333A1 (en) 1998-01-19

Similar Documents

Publication Publication Date Title
NL300272I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
HUP9801608A3 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
BG100974A (en) Vaccines against papillomavirus
ZA962245B (en) Dna encoding human papillomavirus type 18
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
ZA976326B (en) Analogs of cationic proteins.
DE69534778D1 (en) Cathepsin-02-protease
TW222289B (pl)
CA2200582A1 (en) Dna encoding human papillomavirus type 6a
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
AU3711597A (en) A novel galanin receptor
ZA966489B (en) New protein human MP52 Arg.
CA2194032A1 (en) Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein
AU2859892A (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes
AU6456096A (en) Lysine 1689 factor viii:c polypeptide analogs
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ES2191785T3 (es) Proteina de accion antitumoral.
ZA964358B (en) "DNA encoding cellular homologue of the SV40 Large T antigen".
CA2216827A1 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
HUT65363A (en) Midole-ripening, well productiv much aleurone containing bread-wheat "gk zugoly" (triticum aestivum l.)
IT238648Y1 (it) Pedale per l'azionamento di valvole pneumatiche o di interruttorielettrici
AUPN579395A0 (en) Improved powered walking assistant
ZA961162B (en) Mutant proteins.
ITRM940330A0 (it) "procedimento migliorato per la preparazione della 14b-idrossi-etianaldeide".
HK1009465A (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXTF Application for patent extension filed
EXTF Application for patent extension filed
KB Patent renewed
PEL Intention of commissioner to extend period of protection

Free format text: PRODUCT NAME: PROTEIN L1 (TYPE 18

Extension date: 20170719

ERR Corrigendum

Free format text: NO. OF JOURNAL WHERE THE ERROR WAS PUBLISHED: 12/2014 04/2015 THE REQUESTED CORRECTION: NAME OF APPLICANT: PFIZER PRODUCTS, INC. OSI PHARMACEUTICALS, LLC

EXTG Extension of patent term granted

Extension date: 20170719

EXTN Extension order renewed